{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:06:00Z","timestamp":1788354360385,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00467-021-05342-y","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T09:02:45Z","timestamp":1637658165000},"page":"1705-1711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Cystinuria: an update on pathophysiology, genetics, and clinical management"],"prefix":"10.1007","volume":"37","author":[{"given":"Viola","family":"D\u2019Ambrosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Capolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-022X","authenticated-orcid":false,"given":"Pietro Manuel","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"5342_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-7-19","volume":"7","author":"T Eggermann","year":"2012","unstructured":"Eggermann T, Venghaus A, Zerres K (2012) Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis 7:19. https:\/\/doi.org\/10.1186\/1750-1172-7-19","journal-title":"Orphanet J Rare Dis"},{"key":"5342_CR2","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1089\/end.2016.0564","volume":"31","author":"NM Streeper","year":"2017","unstructured":"Streeper NM, Wertheim ML, Nakada SY, Penniston KL (2017) Cystine stone formers have impaired health-related quality of life compared with noncystine stone formers: a case-referent study piloting the Wisconsin Stone Quality of Life Questionnaire among patients with cystine stones. J Endourol 31:S48\u2013S53. https:\/\/doi.org\/10.1089\/end.2016.0564","journal-title":"J Endourol"},{"key":"5342_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/s0022-5347(05)67633-1","volume":"163","author":"F Barbey","year":"2000","unstructured":"Barbey F, Joly D, Rieu P et al (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163:1419\u20131423. https:\/\/doi.org\/10.1016\/s0022-5347(05)67633-1","journal-title":"J Urol"},{"key":"5342_CR4","unstructured":"Leslie SW, Sajjad H, Nazzal L (2020) Cystinuria. In: StatPearls. StatPearls Publishing, Treasure Island (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470527\/"},{"key":"5342_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/ng0494-420","volume":"6","author":"MJ Calonge","year":"1994","unstructured":"Calonge MJ, Gasparini P, Chillar\u00f3n J et al (1994) Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet 6:420\u2013425. https:\/\/doi.org\/10.1038\/ng0494-420","journal-title":"Nat Genet"},{"key":"5342_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1152\/physiol.00051.2004","volume":"20","author":"M Palac\u00edn","year":"2005","unstructured":"Palac\u00edn M, Nunes V, Font-Llitj\u00f3s M et al (2005) The genetics of heteromeric amino acid transporters. Physiology (Bethesda) 20:112\u2013124. https:\/\/doi.org\/10.1152\/physiol.00051.2004","journal-title":"Physiology (Bethesda)"},{"key":"5342_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.semnephrol.2008.01.011","volume":"28","author":"A Mattoo","year":"2008","unstructured":"Mattoo A, Goldfarb DS (2008) Cystinuria. Semin Nephrol 28:181\u2013191. https:\/\/doi.org\/10.1016\/j.semnephrol.2008.01.011","journal-title":"Semin Nephrol"},{"key":"5342_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.juro.2018.07.047","volume":"200","author":"L Reinstatler","year":"2018","unstructured":"Reinstatler L, Stern K, Batter H et al (2018) Conversion from cystine to noncystine stones: incidence and associated factors. J Urol 200:1285\u20131289. https:\/\/doi.org\/10.1016\/j.juro.2018.07.047","journal-title":"J Urol"},{"key":"5342_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.kint.2020.06.035","volume":"99","author":"A Servais","year":"2021","unstructured":"Servais A, Thomas K, Dello Strologo L et al (2021) Cystinuria: clinical practice recommendation. Kidney Int 99:48\u201358. https:\/\/doi.org\/10.1016\/j.kint.2020.06.035","journal-title":"Kidney Int"},{"key":"5342_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1056\/NEJM196512022732303","volume":"273","author":"LE Rosenberg","year":"1965","unstructured":"Rosenberg LE, Durant JL, Holland JM (1965) Intestinal absorption and renal extraction of cystine and cysteine in cystinuria. N Engl J Med 273:1239\u20131245. https:\/\/doi.org\/10.1056\/NEJM196512022732303","journal-title":"N Engl J Med"},{"key":"5342_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1172\/JCI105351","volume":"45","author":"LE Rosenberg","year":"1966","unstructured":"Rosenberg LE, Downing S, Durant JL, Segal S (1966) Cystinuria: biochemical evidence for three genetically distinct diseases. J Clin Invest 45:365\u2013371. https:\/\/doi.org\/10.1172\/JCI105351","journal-title":"J Clin Invest"},{"key":"5342_CR12","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1097\/01.asn.0000029586.17680.e5","volume":"13","author":"L Dello Strologo","year":"2002","unstructured":"Dello Strologo L, Pras E, Pontesilli C et al (2002) Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13:2547\u20132553. https:\/\/doi.org\/10.1097\/01.asn.0000029586.17680.e5","journal-title":"J Am Soc Nephrol"},{"key":"5342_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/12652","volume":"23","author":"L Feliubadal\u00f3","year":"1999","unstructured":"Feliubadal\u00f3 L, Font M, Purroy J et al (1999) Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet 23:52\u201357. https:\/\/doi.org\/10.1038\/12652","journal-title":"Nat Genet"},{"key":"5342_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jmg.2004.022244","volume":"42","author":"M Font-Llitj\u00f3s","year":"2005","unstructured":"Font-Llitj\u00f3s M, Jim\u00e9nez-Vidal M, Bisceglia L et al (2005) New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 42:58\u201368. https:\/\/doi.org\/10.1136\/jmg.2004.022244","journal-title":"J Med Genet"},{"key":"5342_CR15","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2215\/CJN.10981114","volume":"10","author":"HL Rhodes","year":"2015","unstructured":"Rhodes HL, Yarram-Smith L, Rice SJ et al (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol 10:1235\u20131245. https:\/\/doi.org\/10.2215\/CJN.10981114","journal-title":"Clin J Am Soc Nephrol"},{"key":"5342_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.ejhg.5201894","volume":"15","author":"R Parvari","year":"2007","unstructured":"Parvari R, Hershkovitz E (2007) Chromosomal microdeletions and genes\u2019 functions: a cluster of chromosomal microdeletions and the deleted genes\u2019 functions. Eur J Hum Genet 15:997\u2013998. https:\/\/doi.org\/10.1038\/sj.ejhg.5201894","journal-title":"Eur J Hum Genet"},{"key":"5342_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00240-018-1101-7","volume":"47","author":"A Sahota","year":"2019","unstructured":"Sahota A, Tischfield JA, Goldfarb DS et al (2019) Cystinuria: genetic aspects, mouse models, and a new approach to therapy. Urolithiasis 47:57\u201366. https:\/\/doi.org\/10.1007\/s00240-018-1101-7","journal-title":"Urolithiasis"},{"key":"5342_CR18","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.jpurol.2012.08.006","volume":"9","author":"H Nalcacioglu","year":"2013","unstructured":"Nalcacioglu H, Ozden E, Genc G et al (2013) An uncommon cause of acute kidney injury in young children: cystinuria. J Pediatr Urol 9:e58\u2013e63. https:\/\/doi.org\/10.1016\/j.jpurol.2012.08.006","journal-title":"J Pediatr Urol"},{"key":"5342_CR19","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00467-012-2329-z","volume":"28","author":"VO Edvardsson","year":"2013","unstructured":"Edvardsson VO, Goldfarb DS, Lieske JC et al (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28:1923\u20131942. https:\/\/doi.org\/10.1007\/s00467-012-2329-z","journal-title":"Pediatr Nephrol"},{"key":"5342_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/156652408785747997","volume":"8","author":"K Martens","year":"2008","unstructured":"Martens K, Jaeken J, Matthijs G, Creemers JW (2008) Multi-system disorder syndromes associated with cystinuria type I. Curr Mol Med 8:544\u2013550","journal-title":"Curr Mol Med"},{"key":"5342_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2215\/CJN.06680714","volume":"10","author":"C Prot-Bertoye","year":"2015","unstructured":"Prot-Bertoye C, Lebbah S, Daudon M et al (2015) CKD and its risk factors among patients with cystinuria. Clin J Am Soc Nephrol 10:842\u2013851. https:\/\/doi.org\/10.2215\/CJN.06680714","journal-title":"Clin J Am Soc Nephrol"},{"key":"5342_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-5347(05)64824-0","volume":"168","author":"DG Assimos","year":"2002","unstructured":"Assimos DG, Leslie SW, Ng C et al (2002) The impact of cystinuria on renal function. J Urol 168:27\u201330","journal-title":"J Urol"},{"key":"5342_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.juro.2016.12.135","volume":"198","author":"G Gambaro","year":"2017","unstructured":"Gambaro G, Croppi E, Bushinsky D et al (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198:268\u2013273. https:\/\/doi.org\/10.1016\/j.juro.2016.12.135","journal-title":"J Urol"},{"key":"5342_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00240-019-01110-8","volume":"47","author":"F Kum","year":"2019","unstructured":"Kum F, Wong K, Game D et al (2019) Hypertension and renal impairment in patients with cystinuria: findings from a specialist cystinuria centre. Urolithiasis 47:357\u2013363. https:\/\/doi.org\/10.1007\/s00240-019-01110-8","journal-title":"Urolithiasis"},{"key":"5342_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/end.2015.0692","volume":"30","author":"KA Wong","year":"2016","unstructured":"Wong KA, Pardy C, Pillay S et al (2016) Can the presence of crystalluria predict stone formation in patients with cystinuria? J Endourol 30:609\u2013614. https:\/\/doi.org\/10.1089\/end.2015.0692","journal-title":"J Endourol"},{"key":"5342_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.eururo.2015.07.040","volume":"69","author":"C T\u00fcrk","year":"2016","unstructured":"T\u00fcrk C, Pet\u0159\u00edk A, Sarica K et al (2016) EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol 69:468\u2013474. https:\/\/doi.org\/10.1016\/j.eururo.2015.07.040","journal-title":"Eur Urol"},{"key":"5342_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1373\/clinchem.2010.161547","volume":"57","author":"K van Hoeve","year":"2011","unstructured":"van Hoeve K, Vermeersch P, Regal L, Levtchenko E (2011) Necessity of fractionated urine collection for monitoring patients with cystinuria. Clin Chem 57:780\u2013781. https:\/\/doi.org\/10.1373\/clinchem.2010.161547","journal-title":"Clin Chem"},{"key":"5342_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s002400050076","volume":"26","author":"R Finocchiaro","year":"1998","unstructured":"Finocchiaro R, D\u2019Eufemia P, Celli M et al (1998) Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure. Urol Res 26:401\u2013405. https:\/\/doi.org\/10.1007\/s002400050076","journal-title":"Urol Res"},{"key":"5342_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cca.2021.03.017","volume":"518","author":"A Primiano","year":"2021","unstructured":"Primiano A, Persichilli S, Di Giacinto F et al (2021) Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) detection as a rapid and convenient screening test for cystinuria. Clin Chim Acta 518:128\u2013133. https:\/\/doi.org\/10.1016\/j.cca.2021.03.017","journal-title":"Clin Chim Acta"},{"key":"5342_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1067\/mem.2002.126170","volume":"40","author":"A Worster","year":"2002","unstructured":"Worster A, Preyra I, Weaver B, Haines T (2002) The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Ann Emerg Med 40:280\u2013286. https:\/\/doi.org\/10.1067\/mem.2002.126170","journal-title":"Ann Emerg Med"},{"key":"5342_CR31","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/s00345-020-03509-0","volume":"39","author":"H Warren","year":"2020","unstructured":"Warren H, Poon D, Srinivasan R et al (2020) Non-contrast computed tomography characteristics in a large cohort of cystinuria patients. World J Urol 39:2753\u20132757. https:\/\/doi.org\/10.1007\/s00345-020-03509-0","journal-title":"World J Urol"},{"key":"5342_CR32","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1056\/NEJMc1412853","volume":"371","author":"L Andreana","year":"2014","unstructured":"Andreana L, Fiore M (2014) Ultrasonography vs. CT for suspected nephrolithiasis. N Engl J Med 371:2530. https:\/\/doi.org\/10.1056\/NEJMc1412853","journal-title":"N Engl J Med"},{"key":"5342_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/uog.8917","volume":"38","author":"S Amat","year":"2011","unstructured":"Amat S, Czerkiewicz I, Benoist J-F et al (2011) Isolated hyperechoic fetal colon before 36 weeks\u2019 gestation reveals cystinuria. Ultrasound Obstet Gynecol 38:543\u2013547. https:\/\/doi.org\/10.1002\/uog.8917","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5342_CR34","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00467-011-2092-6","volume":"27","author":"DJ Claes","year":"2012","unstructured":"Claes DJ, Jackson E (2012) Cystinuria: mechanisms and management. Pediatr Nephrol 27:2031\u20132038. https:\/\/doi.org\/10.1007\/s00467-011-2092-6","journal-title":"Pediatr Nephrol"},{"key":"5342_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/bju.14721","volume":"124","author":"C Prot-Bertoye","year":"2019","unstructured":"Prot-Bertoye C, Lebbah S, Daudon M et al (2019) Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France. BJU Int 124:849\u2013861. https:\/\/doi.org\/10.1111\/bju.14721","journal-title":"BJU Int"},{"key":"5342_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00240-020-01217-3","volume":"49","author":"JC Williams","year":"2021","unstructured":"Williams JC, Gambaro G, Rodgers A et al (2021) Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis 49:1\u201316. https:\/\/doi.org\/10.1007\/s00240-020-01217-3","journal-title":"Urolithiasis"},{"key":"5342_CR37","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/s0022-5347(17)40222-9","volume":"143","author":"RW Norman","year":"1990","unstructured":"Norman RW, Manette WA (1990) Dietary restriction of sodium as a means of reducing urinary cystine. J Urol 143:1193\u20131195. https:\/\/doi.org\/10.1016\/s0022-5347(17)40222-9","journal-title":"J Urol"},{"key":"5342_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/end.2005.19.429","volume":"19","author":"DJ Dolin","year":"2005","unstructured":"Dolin DJ, Asplin JR, Flagel L et al (2005) Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol 19:429\u2013432. https:\/\/doi.org\/10.1089\/end.2005.19.429","journal-title":"J Endourol"},{"key":"5342_CR39","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00467-007-0575-2","volume":"22","author":"L Dello Strologo","year":"2007","unstructured":"Dello Strologo L, Laurenzi C, Legato A, Pastore A (2007) Cystinuria in children and young adults: success of monitoring free-cystine urine levels. Pediatr Nephrol 22:1869\u20131873. https:\/\/doi.org\/10.1007\/s00467-007-0575-2","journal-title":"Pediatr Nephrol"},{"key":"5342_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-004-1663-1","volume":"20","author":"T Knoll","year":"2005","unstructured":"Knoll T, Z\u00f6llner A, Wendt-Nordahl G et al (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20:19\u201324. https:\/\/doi.org\/10.1007\/s00467-004-1663-1","journal-title":"Pediatr Nephrol"},{"key":"5342_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.21037\/atm.2019.07.42","volume":"7","author":"H Zhong","year":"2019","unstructured":"Zhong H, Wang L, Gu Z-C et al (2019) Minimal change disease induced by tiopronin: a rare case report and a review of the literature. Ann Transl Med 7:398. https:\/\/doi.org\/10.21037\/atm.2019.07.42","journal-title":"Ann Transl Med"},{"key":"5342_CR42","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1089\/end.2019.0703","volume":"34","author":"BH Eisner","year":"2020","unstructured":"Eisner BH, Goldfarb DS, Baum MA et al (2020) Evaluation and medical management of patients with cystine nephrolithiasis: a consensus statement. J Endourol 34:1103\u20131110. https:\/\/doi.org\/10.1089\/end.2019.0703","journal-title":"J Endourol"},{"key":"5342_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejim.2006.03.001","volume":"17","author":"GS Habib","year":"2006","unstructured":"Habib GS, Saliba W, Nashashibi M, Armali Z (2006) Penicillamine and nephrotic syndrome. Eur J Intern Med 17:343\u2013348. https:\/\/doi.org\/10.1016\/j.ejim.2006.03.001","journal-title":"Eur J Intern Med"},{"key":"5342_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0272-6386(86)80019-1","volume":"8","author":"KA Ntoso","year":"1986","unstructured":"Ntoso KA, Tomaszewski JE, Jimenez SA, Neilson EG (1986) Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature. Am J Kidney Dis 8:159\u2013163. https:\/\/doi.org\/10.1016\/s0272-6386(86)80019-1","journal-title":"Am J Kidney Dis"},{"key":"5342_CR45","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.juro.2009.04.084","volume":"182","author":"EH Landau","year":"2009","unstructured":"Landau EH, Shenfeld OZ, Pode D et al (2009) Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor. J Urol 182:1835\u20131839. https:\/\/doi.org\/10.1016\/j.juro.2009.04.084","journal-title":"J Urol"},{"key":"5342_CR46","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.1111\/j.1464-410X.2012.11352.x","volume":"111","author":"J Cohen","year":"2013","unstructured":"Cohen J, Cohen S, Grasso M (2013) Ureteropyeloscopic treatment of large, complex intrarenal and proximal ureteral calculi. BJU Int 111:E127\u2013E131. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11352.x","journal-title":"BJU Int"},{"key":"5342_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11926-015-0510-7","volume":"17","author":"MH Lee","year":"2015","unstructured":"Lee MH, Sahota A, Ward MD, Goldfarb DS (2015) Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases. Curr Rheumatol Rep 17:33. https:\/\/doi.org\/10.1007\/s11926-015-0510-7","journal-title":"Curr Rheumatol Rep"},{"key":"5342_CR48","doi-asserted-by":"publisher","first-page":"1249.e9","DOI":"10.1016\/j.urology.2014.07.043","volume":"84","author":"A Sahota","year":"2014","unstructured":"Sahota A, Parihar JS, Capaccione KM et al (2014) Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model. Urology 84:1249.e9\u201315. https:\/\/doi.org\/10.1016\/j.urology.2014.07.043","journal-title":"Urology"},{"key":"5342_CR49","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.bmcl.2018.03.024","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Albanyan H, Lee S et al (2018) Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria. Bioorg Med Chem Lett 28:1303\u20131308. https:\/\/doi.org\/10.1016\/j.bmcl.2018.03.024","journal-title":"Bioorg Med Chem Lett"},{"key":"5342_CR50","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.4280","volume":"23","author":"T Zee","year":"2017","unstructured":"Zee T, Bose N, Zee J et al (2017) \u03b1-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria. Nat Med 23:288\u2013290. https:\/\/doi.org\/10.1038\/nm.4280","journal-title":"Nat Med"},{"key":"5342_CR51","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7326\/0003-4819-157-6-201209180-00023","volume":"157","author":"H de Boer","year":"2012","unstructured":"de Boer H, Roelofsen A, Janssens PMW (2012) Antidiuretic hormone antagonist to reduce cystine stone formation. Ann Intern Med 157:459\u2013460. https:\/\/doi.org\/10.7326\/0003-4819-157-6-201209180-00023","journal-title":"Ann Intern Med"},{"key":"5342_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00345-020-03166-3","volume":"39","author":"Y Bai","year":"2021","unstructured":"Bai Y, Tang Y, Wang J et al (2021) Tolvaptan treatment of cystine urolithiasis in a mouse model of cystinuria. World J Urol 39:263\u2013269. https:\/\/doi.org\/10.1007\/s00345-020-03166-3","journal-title":"World J Urol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05342-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05342-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05342-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T03:15:30Z","timestamp":1657077330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05342-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["5342"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05342-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"assertion":[{"value":"15 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PMF received consultant fees\/grant support from Allena Pharmaceuticals, Alnylam, AstraZeneca, BioHealth Italia, Vifor Fresenius and author royalties from UpToDate. All of the other authors have no potential conflicts of interest to disclose. VDA, GC, and PMF are members of the European Reference Network for Rare Kidney Diseases (ERKNet) \u2013 Project ID No 739532.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}